BioMed Research International

Research Article

Factors Associated with RANTES Concentration in Cardiovascular Disease Patients

Table 3

RANTES and CCL2 results in AMI patients, SA subjects, and control group. Results are presented as median and interquartiles.
PARAMETERAMISTEMINSTEMISACAMI vs. SA
STEMI vs. SA
NSTEMI vs. SA		STEMI
vs. NSTEMI		AMI vs. C
STEMI vs. C
NSTEMI vs. C
SA vs. C
RANTES
pg/mL		4800
(2596-7244)		3820
(1992-6292)		5412
(3856-8104)		5884
(3808-6684)		1724
(1332-2564)		NS
NS
NS		NS
<0.001 
0.008 
<0.001 
<0.001
CCL2
pg/mL		180
(168-226)		176
(160-210)		190
(172-246)		210
(184-266)		152
(114-206)		NS
NS
NS		NS
NS
NS
NS
0.004
AMI: acute myocardial infarction, CCL2: Monocyte Chemotactic Protein 1, NS: not statistically significant, NSTEMI: non-ST elevation myocardial infarction, RANTES: Regulated upon Activation, Normal T cell Expressed and presumably Secreted, SA: stable angina, STEMI: ST elevation myocardial infarction.